ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients

Clinical trial NCT04588311 · RECRUITING

Trial details

NCT number: NCT04588311
Sponsor: Australian and New Zealand Intensive Care Research Centre
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Trauma Traumatic Injury Traumatic Brain Injury Wounds and Injuries Penetrating Injury Blunt Injury Major Trauma Multiple Trauma

Start date: 2020-11-09
Primary completion: 2026-12-31
Enrollment: 2500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.